Bigfoot Biomedical

MILPITAS, CA · Founded 2014 · Medtech · Acquired

Integrated continuous glucose monitoring system with AI-powered insulin dose recommendation engine for multiple daily injection diabetes management

Claim this profile

Follows are private to you and power your alerts

Updated · bigfootbiomedical.com

Sector
Medtech
Headquarters
MILPITAS, CA
Founded
2014
Latest Form D
$45.9M, Jan 2020
Total capital
$132M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$132M
7 Form D · last Jan 2020
81 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
20
20 pending · first 2024
Rank in peer group#7 of 1112

Capital timeline

201520162017201820192020FEDERAL ↑EQUITY ↓Cumulative $132M1st Form D$3M6th Form D$37.1M7th Form D$45.9M
201520162017201820192020FEDERAL ↑EQUITY ↓Cumulative $132M7th Form D$45.9M

Latest events

  • Private capital raisedForm D · SEC · 7th filing$45.9M
  • Private capital raisedForm D · SEC · 6th filing$37.1M
  • Private capital raisedForm D · SEC · 5th filing$5.2M
  • Private capital raisedForm D · SEC · 4th filing$34.7M
  • Private capital raisedForm D · SEC · 3rd filing$2.4M
  • Private capital raisedForm D · SEC · 2nd filing$3.8M
  • Private capital raisedForm D · SEC · 1st filing$3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#7 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Bob KavnerDirectorNamed in SEC Form D filings
  • Brett HaleExecutive OfficerNamed in SEC Form D filings
  • Bryan MazlishExecutive Officer, DirectorNamed in SEC Form D filings
  • Jeffrey BrewerExecutive Officer, DirectorNamed in SEC Form D filings
  • Jon BrilliantExecutive OfficerNamed in SEC Form D filings
  • Joy MashaalDirectorNamed in SEC Form D filings
Show all 9 people
  • Karen TalmadgeDirectorNamed in SEC Form D filings
  • Karen TalmageDirectorNamed in SEC Form D filings
  • Thomas BrenerDirectorNamed in SEC Form D filings

What it has protected

USPTO · 20 granted of 40
  • GrantedDiabetes Management SystemUSPTOUS 12,734,290
  • GrantedTherapy Data Management SystemUSPTOUS 12,683,003
  • PendingComputing Architecture For Assuring The Provenance Of Medication Therapy Related Parameters, And Related Systems, Methods And DevicesUSPTOApplication 19548666
Show all 40 patent records
  • Supira MedicalSimilar federal contract value in Medtech · null in contracts
  • Centinel Spine, LLCSimilar federal contract value in Medtech · null in contracts
  • Vascular Perfusion Solutions, Inc.Similar federal contract value in Medtech · null in contracts
  • Rad AI, Inc.Similar federal contract value in Medtech · null in contracts
  • Seer BioSimilar federal contract value in Medtech · null in contracts
  • Kardium Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .